An investigator intitiated clnical trial for evaluating the efficacy and safety of 131I-Rituximab treatment as consolidation in the patients with CD20 positive advanced diffuse large B-cell lymphoma after standard combination chemotherapy

Trial Profile

An investigator intitiated clnical trial for evaluating the efficacy and safety of 131I-Rituximab treatment as consolidation in the patients with CD20 positive advanced diffuse large B-cell lymphoma after standard combination chemotherapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs Rituximab (Primary) ; Chlorphenamine; Paracetamol
  • Indications Diffuse large B cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top